Stocks Mixed on Strength in Chipmakers vs Weakness in Software Companies
US stocks are mixed, with chipmakers and AI-infrastructure stocks rising, while software companies decline. Treasury Secretary Bessent announced upcoming economic measures against Iran. S&P 500 is tracking for 32% Q2 earnings growth, with 85% of companies beating estimates. Marvell (MRVL) and Sandisk (SNDK) lead gains, while Datadog (DDOG) and Salesforce (CRM) lead losses. Astera Labs (ALAB) and Onto Innovation (ONTO) received upgrades, while EyePoint (EYPT) plunged after a failed trial.
How this was made
The 30-second read
Why it matters
Traders can use the same-day catalysts cited for specific names (upgrades, downgrades, clinical trial failure, executive step-down, and Berkshire’s liquidation) while treating the rest of the sector moves as tape-driven.
Market read
Semis/AI infrastructure are bid while software is sold, but the most tradable signals come from discrete company-specific catalysts listed in the movers section.
What to watch
The article provides no details on whether the chip strength is tied to specific earnings/guidance, so follow-through risk is higher if it is purely positioning.
Background
The piece is a daily market wrap mixing macro drivers (rates, oil, inflation expectations) with a basket of single-stock movers.
Ticker impact
Marvell Technology is up more than 5% today, cited as leading S&P 500 gainers amid chipmaker strength.
Likely supports continued relative strength intraday, but no new fundamental catalyst is disclosed.
The article attributes the move to sector strength and does not provide a fresh company-specific news item beyond the price action.
Datadog is down more than 3% today, leading Nasdaq 100 losers as software stocks face pressure.
May remain under pressure while software sentiment stays weak, absent new DDOG-specific news.
The text frames the move as part of broader software weakness and provides no new DDOG fundamental disclosure.
Salesforce is down more than 2% today, described as leading Dow Jones Industrials losers alongside software weakness.
Could see continued underperformance versus chipmakers if the sector rotation persists.
The article links the decline to software weakness but does not cite a new Salesforce-specific catalyst.
ServiceNow is down more than 2% today, listed among software names weighing on the broader market.
Near-term bias remains soft while software complex is out of favor.
The move is presented as part of a basket of software decliners without any new NOW-specific event.
Astera Labs is up more than 6% after Northland Securities upgraded it to outperform with a $350 price target.
Supports upside follow-through risk in the near term, especially if upgrade chatter spreads.
The article includes a specific upgrade action and a stated price target, which is actionable and time-sensitive.
Onto Innovation is up more than 4% after Goldman Sachs initiated a buy rating with a $400 price target.
Increases probability of continued strength versus peers near term.
The text explicitly states the initiation, rating, and price target, indicating a concrete new driver.
Target Hospitality is up more than 2% after Morgan Stanley initiated coverage with an overweight recommendation and a $22 price target.
May attract incremental speculative/positioning flows around the initiation.
The catalyst is clear, but the article does not provide additional fundamentals or follow-on details.
EyePoint is down more than 71% after saying its experimental eye-disease treatment failed its primary goal in a late-stage trial.
Further downside volatility likely as investors reassess the development path and timelines.
The article discloses a specific late-stage trial outcome and magnitude of the stock reaction, which is primary and decision-relevant.
Market effects
Semiconductor and AI-infrastructure strength is offset by broad software weakness, reinforcing a rotation trade within equities.
Overseas markets are mixed, with China and Japan higher while Europe is slightly lower, supporting a cautious risk tone.
Higher oil and inflation expectations are weighing on Treasuries, which can spill into equity duration-sensitive sectors.
Counterpoint
The large moves in several software and biotech names may be idiosyncratic, so broad sector rotation may be overstated.
Key entities
- companyAstera Labs
Upgraded to outperform by Northland Securities with a $350 price target.
- companyOnto Innovation
Goldman Sachs initiated coverage with a buy rating and $400 price target.
- companyEyePoint
Late-stage trial failed to meet the primary goal for an experimental eye treatment.
- companyL3Harris Technologies
CEO and chairman Christopher Kubasik stepped down effective immediately.
- companyConstellation Brands
Berkshire Hathaway liquidated its holdings, prompting a sharp decline.
